Authors:
Mohr, M
Dalmis, F
Hilgenfeld, E
Oelmann, E
Zuhlsdorf, M
Kratz-Albers, K
Nolte, A
Schmitmann, C
Onaldi-Mohr, D
Cassens, U
Serve, H
Sibrowski, W
Kienast, J
Berdel, WE
Citation: M. Mohr et al., Simultaneous immunomagnetic CD34+cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma, CLIN CANC R, 7(1), 2001, pp. 51-57
Authors:
Koch, P
del Valle, F
Berdel, WE
Willich, NA
Reers, B
Hiddemann, W
Grothaus-Pinke, B
Reinartz, G
Brockmann, J
Temmesfeld, A
Schmitz, R
Rube, C
Probst, A
Jaenke, G
Bodenstein, H
Junker, A
Pott, C
Schultze, J
Heinecke, A
Parwaresch, R
Tiemann, M
Citation: P. Koch et al., Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92, J CL ONCOL, 19(18), 2001, pp. 3861-3873
Authors:
Koch, P
del Valle, F
Berdel, WE
Willich, NA
Reers, B
Hiddemann, W
Grothaus-Pinke, B
Reinartz, G
Brockmann, J
Temmesfeld, A
Schmitz, R
Rube, C
Probst, A
Jaenke, G
Bodenstein, H
Junker, A
Pott, C
Schultze, J
Heinecke, A
Parwaresch, R
Tiemann, M
Citation: P. Koch et al., Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical andconservative or conservative management only in localized gastric lymphoma- Results of the Prospective German Multicenter Study GIT NHL 01/92, J CL ONCOL, 19(18), 2001, pp. 3874-3883
Authors:
Rick, O
Bokemeyer, C
Beyer, J
Hartmann, JT
Schwella, N
Kingreen, D
Neureither, S
Metzner, B
Casper, J
Wandt, H
Hartmann, F
Schmoll, HJ
Derigs, G
Gerl, A
Berdel, WE
Kanz, L
Siegert, W
Citation: O. Rick et al., Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer, J CL ONCOL, 19(1), 2001, pp. 81-88
Authors:
Cassens, U
Momkvist, PH
Zuehlsdorf, M
Mohr, M
Kienast, J
Berdel, WE
Sibrowski, W
Citation: U. Cassens et al., Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC), BONE MAR TR, 28(1), 2001, pp. 13-20
Authors:
Thomas, M
Broermann, P
Droege, C
Lerchenmuller, C
Berdel, WE
Citation: M. Thomas et al., Development of treatment strategies in locally advanced non-small cell lung cancer (take home messages), LUNG CANC, 33, 2001, pp. S91-S97
Authors:
Muller-Tidow, C
Bornemann, C
Diederichs, S
Westermann, A
Klumpen, S
Zuo, PJ
Wang, WB
Berdel, WE
Serve, H
Citation: C. Muller-tidow et al., Analyses of the genomic methylation status of the human cyclin A1 promoterby a novel real-time PCR-based methodology, FEBS LETTER, 490(1-2), 2001, pp. 75-78
Authors:
Muller-Tidow, C
Metzger, R
Kugler, K
Diederichs, S
Idos, G
Thomas, M
Dockhorn-Dworniczak, B
Schneider, PM
Koeffler, HP
Berdel, WE
Serve, H
Citation: C. Muller-tidow et al., Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer, CANCER RES, 61(2), 2001, pp. 647-653
Authors:
Hilgenfeld, E
Padilla-Nash, H
McNeil, N
Knutsen, T
Montagna, C
Tchinda, J
Horst, J
Ludwig, WD
Serve, H
Buchner, T
Berdel, WE
Schrock, E
Ried, T
Citation: E. Hilgenfeld et al., Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2, BR J HAEM, 113(2), 2001, pp. 305-317
Authors:
Muller-Tidow, C
Kugler, K
Diederichs, S
Klumpen, S
Moller, M
Vogt, U
Metzger, R
Schneider, PM
Berdel, WE
Serve, H
Citation: C. Muller-tidow et al., Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer, BR J CANC, 85(8), 2001, pp. 1168-1174
Authors:
Renz, A
Berdel, WE
Kreuter, M
Belka, C
Schulze-Osthoff, K
Los, M
Citation: A. Renz et al., Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo, BLOOD, 98(5), 2001, pp. 1542-1548
Authors:
Mesters, RM
Padro, T
Bieker, R
Steins, M
Kreuter, M
Goner, M
Kelsey, S
Scigalla, P
Fiedler, W
Buchner, T
Berdel, WE
Citation: Rm. Mesters et al., Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia, BLOOD, 98(1), 2001, pp. 241-243
Authors:
Muller-Tidow, C
Wang, WB
Idos, GE
Diederichs, S
Yang, R
Readhead, C
Berdel, WE
Serve, H
Saville, M
Watson, R
Koeffler, HP
Citation: C. Muller-tidow et al., Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function, BLOOD, 97(7), 2001, pp. 2091-2097
Citation: C. Lerchenmuller et al., Phase I study of liposomal daunorubicin (DaunoXome) in relapsed and refractory acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 191-195
Authors:
Schumacher, A
Wewers, D
Buchner, T
Berdel, WE
Citation: A. Schumacher et al., Including quality of life as an important end point in evaluating intensive and prolonged treatment for acute myeloid leukemia (AML), HEMAT BLOOD, 40, 2001, pp. 482-487
Authors:
Scheulen, ME
Hilger, RA
Oberhoff, C
Casper, J
F'reund, M
Josten, KM
Bornhauser, M
Ehninger, G
Berdel, WE
Baumgart, J
Harstrick, A
Bojko, P
Wolf, HH
Schindler, AE
Seeber, S
Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216
Authors:
Matzkies, FK
Tombach, B
Dietrich, M
Kisters, K
Barenbrock, M
Schaefer, RM
Berdel, WE
Rahn, KH
Citation: Fk. Matzkies et al., MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient, NEPH DIAL T, 15(1), 2000, pp. 110-112
Authors:
Mross, K
Robben-Bathe, P
Edler, L
Baumgart, J
Berdel, WE
Fiebig, H
Unger, C
Citation: K. Mross et al., Phase I clinical trial of a day-1,-3,-5 every 3 weeks schedule with titanocene dichloride (MKT 5) in patients with advanced cancer - A study of the phase I study group of the Association for Medical Oncology (AIO) of the German Cancer Society, ONKOLOGIE, 23(6), 2000, pp. 576-579
Authors:
Muller, C
Readhead, C
Diederichs, S
Idos, G
Yang, R
Tidow, N
Serve, H
Berdel, WE
Koeffler, HP
Citation: C. Muller et al., Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent, MOL CELL B, 20(9), 2000, pp. 3316-3329
Authors:
Szelenyi, H
Hohenberger, P
Lochs, H
Haboubi, N
Berdel, WE
Thiel, E
Kreuser, ED
Citation: H. Szelenyi et al., Sequential trimetrexate, 5-fluorouracil and folinic acid are effective andwell tolerated in metastatic colorectal carcinoma, ONCOL-BASEL, 58(4), 2000, pp. 273-279